Ex Parte No Data - Page 2



                Appeal  2007-0686                                                                            
                Reexamination Control 90/004,812                                                             
                Application 09/810,650                                                                       
                other pending claim in this appeal, has been indicated as allowable.1  We                    
                have jurisdiction under 35 U.S.C. § 6(b).  We affirm.                                        
                                                Introduction                                                 
                      U.S. Patent 5,216,135 (the '135 patent) was issued to Urano et al. on                  
                June 1, 1993, based on application 07/962,089, filed October 16, 1992,                       
                which is said to be a continuation of application 07/646,909, filed                          
                January 28, 1991.  The '135 patent is assigned to Wako Pure Chemical                         
                Industries, Ltd. (Wako) and is directed to compounds useful in                               
                manufacturing semiconductor devices and claims certain diazodisulfone                        
                compounds useful as photosensitive materials.  A request for reexamination                   
                by a third party was filed on October 23, 1997 and the reexamination                         
                proceeding was assigned control number 90/004,812.  Wako filed a reissue                     
                application on March 15, 2001 which was assigned application number                          
                09/810,650.  The reexamination and reissue proceedings were merged on                        
                November 7, 2001.                                                                            
                      Appellants admit that reissue claims 8 and 10 are duplicates and                       
                reissue claims 9 and 11 are duplicates (Appeal Br. 18, filed April 27, 2006)                 
                and state that claims 10 and 11 "will be canceled when all claims are                        
                allowed" (Appeal Br. 20).  Thus, the claims on appeal recite diazodisulfone                  
                compounds of the general formula                                                             

                                                                                                            
                1 An amendment filed June 1, 2006 canceling reissue claims 12-35 was                         
                entered by the Examiner July 5, 2006 (see Advisory Action mailed July 5,                     
                2006).  Thus, only reissue claims 7-11 are currently pending in this merged                  
                reissue/reexamination proceeding.                                                            
                                                     2                                                       

Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next

Last modified: September 9, 2013